J. Joyce

发表

Human striatal dopamine receptors are organized in compartments.

J. Marshall, J. Joyce, D. Sapp, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

Sabine Borwege, J. Joyce, C. Woolsey, 2004, BMC Biology.

Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.

J. Joyce, B. Neal-Beliveau, 1999, Neurotoxicology and teratology.

Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.

J. Joyce, B. Neal-Beliveau, 1998, Developmental psychobiology.

Delayed plasticity of the mesolimbic dopamine system following neonatal 6‐OHDA lesions

J. Joyce, P. Frohna, B. Neal-Beliveau, 1997, Synapse.

Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

Sabine Borwege, J. Joyce, T. Ahmed, 2009, Neurotoxicity Research.

Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E

Shuichi Ueda, S. Sakakibara, J. Joyce, 2005, Neuroscience Letters.

The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system

K. Yoshimoto, J. Joyce, S. Ueda, 2000, Neuroreport.

Loss of D3 receptors in the zitter mutant rat is not reversed by l-dopa treatment

S. Sakakibara, J. Joyce, S. Ueda, 2004, Experimental Neurology.

Developmental Plasticity of Dopamine Systems: Pre- and Post-Synaptic Components of the Dopamine System are Modified by Neonatal Lesions

J. Joyce, B. Neal-Beliveau, 1994 .

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

J. Joyce, H. Ryoo, Dylan Pierrotti, 1998, Movement disorders : official journal of the Movement Disorder Society.

Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease

A. Myers, J. Joyce, E. Gurevich, 1998, Brain Research.

Methamphetamine‐induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations

J. Joyce, D. Dluzen, T. Osredkar, 2004, Synapse.

Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism

J. Schneider, J. Joyce, P. Frohna, 1995, Synapse.

Increased number of [125I] BH-substance p receptors in schizophrenia

J. Joyce, J. Nissanov, L. Rioux, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.

J. Joyce, B. Neal-Beliveau, W. S. Thomas, 1998, Brain research. Developmental brain research.

Ontogeny of the dopamine D2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex

J. Kordower, J. Joyce, E. Gurevich, 2000, Journal of Chemical Neuroanatomy.

Dopamine-mediated behaviors: Characteristics of modulation by estrogen

J. Joyce, C. V. Hartesveldt, Eddie Montero, 1984, Pharmacology Biochemistry and Behavior.

Dopamine D2 receptors are organized in bands in normal human temporal cortex

J. Joyce, S. K Goldsmith, J. N Joyce, 1996, Neuroscience.

The pattern of dopamine D2 receptors in medial temporal lobe of control and schizophrenic human postmortem brain

J. Joyce, S. Goldsmith, 1993, Schizophrenia Research.

[3H]Hemicholinium-3 binding in rabbit striatum: correspondence with patchy acetylcholinesterase staining and a method for quantifying striatal compartments

K. Rhodes, J. Joyce, J. Marshall, 1987, Brain Research.

J. Joyce, T. Der, A. Iarkov, 2010, European journal of pharmacology.

Behavioural Pharmacology Age-related differences in MK-801 induced behaviors in dopamine D3 receptor knock out mice

J. Joyce, T. Der, A. Iarkov, 2010 .

Environmental complexity modulates growth of granule cell dendrites in developing but not adult hippocampus of rats

W. Greenough, J. Joyce, B. Fiala, 1978, Experimental Neurology.

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

M. Millan, J. Joyce, T. Osredkar, 2003, Experimental Neurology.

Upregulation of Arc mRNA expression in the prefrontal cortex following cue‐induced reinstatement of extinguished cocaine‐seeking behavior

J. Joyce, J. Neisewander, T. Osredkar, 2008, Synapse.

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

T. Duka, A. Sidhu, J. Joyce, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Multiple dopamine receptors and behavior

J. Joyce, 1983, Neuroscience & Biobehavioral Reviews.

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

J. Rogers, D. Mastroeni, A. Grover, 2007, International review of neurobiology.

Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.

J. Joyce, N. Rowland, L. Bellush, 1985, Behavioral neuroscience.

The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

J. Joyce, 2005, Psychopharmacology.

Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system

J. Joyce, 1991, Experimental Neurology.

Functional and Molecular Differentiation of the Dopamine System Induced by Neonatal Denervation

J. Joyce, P. Frohna, B. Neal-Beliveau, 1996, Neuroscience & Biobehavioral Reviews.

Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study.

P. Molinoff, J. Joyce, P. A. Rao, 1991, Brain research. Developmental brain research.

Estradiol application to one striatum produces postural deviation to systemic apomorphine

J. Joyce, C. V. Hartesveldt, 1984, Pharmacology Biochemistry and Behavior.

Behaviors induced by intrastriatal dopamine vary independently across the estrous cycle

J. Joyce, C. V. Hartesveldt, 1984, Pharmacology Biochemistry and Behavior.

Effects of estrogen on the basal ganglia

J. Joyce, C. V. Hartesveldt, C. Hartesveldt, 1986, Neuroscience & Biobehavioral Reviews.

Neurochemical Lesioning Techniques for Assessing Regulation of Monoamine Receptors

J. Hensler, J. Joyce, S. Tejani-butt, 1991 .

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

J. Joyce, E. Gurevich, 1997, Biological Psychiatry.

A neural substrate of hyperactivity in borna disease: changes in brain dopamine receptors.

G. Koob, J. Joyce, W. Lipkin, 1996, Virology.

Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers

T. Beach, D. Walker, J. Joyce, 2004, Journal of neuropathology and experimental neurology.

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease

A. Myers, G. Smutzer, C. Whitty, 1997, Movement disorders : official journal of the Movement Disorder Society.

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.

M. Bilgen, J. Rajadas, Tao Yang, 2010, The Journal of clinical investigation.

Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics

J. Kleinman, M. Casanova, J. Joyce, 1993, Neuropsychopharmacology.

c‐Fos expression associated with reinstatement of cocaine‐seeking behavior by response‐contingent conditioned cues

J. Joyce, J. Neisewander, P. Kufahl, 2009, Synapse.

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

A. Sidhu, J. Joyce, Jessica M Jones, 2010, Experimental Neurology.

Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia

J. Meador-Woodruff, J. Joyce, Jeffrey N Joyce, 1997, Neuropsychopharmacology.

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

R. Gur, S. Arnold, J. Joyce, 1997, Archives of general psychiatry.

Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes.

J. Joyce, E. Gurevich, S. Goldsmith, 1997, Journal of psychiatric research.

Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor.

J. Joyce, T. Der, A. Yarkov, 2010, European journal of pharmacology.

Dopamine D3 receptor antagonists as therapeutic agents.

M. Millan, J. Joyce, Jeffrey N Joyce, 2005, Drug discovery today.

Distribution of beta‐adrenergic receptor subtypes in human post‐mortem brain: Alterations in limbic regions of schizophrenics

J. Kleinman, E. Bird, J. Joyce, 1992, Synapse.

Alterations in Limbic Regions of Schizophrenics

J. Kleinman, E. Bird, J. Joyce, 1992 .

D3 Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics

J. Joyce, E. Gurevich, 1999, Annals of the New York Academy of Sciences.

Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.

J. Joyce, R. Shapiro, S. Goldsmith, 1997, Archives of general psychiatry.

Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons

J. Joyce, E. Gurevich, Jeffrey N Joyce, 1999, Neuropsychopharmacology.

Developing a Sustainable Research Culture in an Independent Academic Medical Center.

J. Joyce, 2013 .

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.

J. Joyce, E. Gurevich, H. Ryoo, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease

J. Joyce, H. Ryoo, S. Goldsmith, 1993, Neuroscience Letters.

Microglial responses to dopamine in a cell culture model of Parkinson's disease

J. Rogers, D. Mastroeni, A. Grover, 2009, Neurobiology of Aging.

Serotonergic involvement in haloperidol-induced catalepsy.

I. Lucki, J. Joyce, B. Neal-Beliveau, 1993, The Journal of pharmacology and experimental therapeutics.

Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.

K. Neve, A. Janowsky, J. Joyce, 1991, The Journal of pharmacology and experimental therapeutics.

Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density

D. Jacobowitz, I. Kopin, J. Joyce, 1986, Brain Research.

Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs

J. Joyce, P. Frohna, B. Neal-Beliveau, 1995, Neuroscience.

Neonatal 6‐OHDA Lesions differentially affect striatal D1 and D2 receptors

J. Joyce, B. Neal, 1992, Synapse.

Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia

J. Benovic, J. Joyce, V. Gurevich, 2008, Neurobiology of Aging.

The Basal Ganglia Dopaminergic Systems in Normal Aging and Parkinson's Disease

J. Joyce, 2001 .

Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors.

C. Adler, J. Caviness, J. Hentz, 2002, Parkinsonism & related disorders.

Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation.

J. Joyce, C. van Hartesveldt, R. Smith, 1982, European journal of pharmacology.

Systemic apomorphine reverses intrastriatal dopamine-induced contralateral deviation.

R. Davis, J. Joyce, C. van Hartesveldt, 1983, European journal of pharmacology.

Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum.

R. Davis, J. Joyce, C. van Hartesveldt, 1981, European journal of pharmacology.

Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.

M. Millan, Sabine Borwege, J. Joyce, 2004, Experimental neurology.

Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in alzheimer's disease

J. Joyce, H. Ryoo, 1994, The Journal of comparative neurology.

Ventral striatal D3 receptors and Parkinson's Disease

C. Adler, T. Beach, J. Joyce, 2001 .

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.

J. Joyce, 2001, Pharmacology & therapeutics.

Associate editor: K.A. Neve Dopamine D 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

J. Joyce, 2001 .

The effects of chronic levodopa treatment on pre‐ and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys

J. Schneider, J. Joyce, P. Frohna, 1997, Movement disorders : official journal of the Movement Disorder Society.

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease.

M. Millan, J. Joyce, Jeffrey N Joyce, 2007, Current opinion in pharmacology.

Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation

J. Joyce, J. Marshall, Steve K. Loeschen, 1985, Brain Research.

Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization

J. Joyce, J. Marshall, 1985, Neuroscience Letters.

Basal Ganglia Dopamine Receptor Autoradiography and Age‐related Movement Disorders a

J. Joyce, J. Marshall, 1988, Annals of the New York Academy of Sciences.

Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia

E. Bird, J. Joyce, A. Winokur, 1988, Synapse.

D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period

J. Joyce, J N Joyce, 2001, Synapse.

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

J. Joyce, J. Marshall, R. Navarrete, 1989, Brain Research.

Increases in Dopamine D3 Receptor Binding in Rats Receiving a Cocaine Challenge at Various Time Points after Cocaine Self-Administration: Implications for Cocaine-Seeking Behavior

R. A. Fuchs, S. Weber, J. Joyce, 2004, Neuropsychopharmacology.

Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

G. Gottleib, J. Joyce, H. Hurtig, 1995, Annals of neurology.

Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment

J. Joyce, 1991, Experimental Neurology.

Diabetes mellitus affects prostaglandin E2 levels in mouse embryos during neurulation

J. Joyce, P. Dhanasekaran, L. Baker, 1996, Diabetologia.

Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase‐immunoreactive fibers

J. Joyce, S. Goldsmith, 1994, Hippocampus.

Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors

M. Reiser, C. Adler, J. Caviness, 2002, Brain Research.

Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease

J. Joyce, L. Rioux, 1993, Journal of neural transmission. Parkinson's disease and dementia section.

Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant.

J. Joyce, H. Hurtig, 1990, Progress in brain research.

Comparison of [3H]Paroxetine and [3H]Cyanoimipramine for Quantitative Measurement of Serotonin Transporter Sites in Human Brain

J. Joyce, E. Gurevich, Jeffrey N Joyce, 1996, Neuropsychopharmacology.

S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: II. Actions in Rodent, Primate, and Cellular Models of Antiparkinsonian Activity in Comparison to Ropinirole

M. Millan, J. Brotchie, A. Gobert, 2004, Journal of Pharmacology and Experimental Therapeutics.

Rotation and postural deviation elicited by microinjections of dopamine into medial and lateral regions of dorsal striatum

J. Joyce, C. V. Hartesveldt, 1984, Pharmacology Biochemistry and Behavior.

J. Joyce, J. Marshall, D. W. Sapp, 1986, Brain Research.

Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice

D. Hanger, J. Joyce, Jeffrey N Joyce, 2003, Pharmacology Biochemistry and Behavior.

Dopamine D2 receptor mRNA is expressed in maturing neurons of the human hippocampal and subicular fields

J. Kordower, J. Joyce, E. Gurevich, 1997, Neuroreport.

Striosomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: a quantitative receptor autoradiographic study

J. Marshall, J. Coyle, J. Joyce, 1990, Brain Research.

Dopamine D3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat

J. Joyce, E. Gurevich, 2000, The Journal of comparative neurology.

Involvement of dopamine D2/D3 receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells

M. Millan, Sabine Borwege, J. Joyce, 2004, Experimental Neurology.

Alterations in hippocampal mossy fiber pathway in Schizophrenia and Alzheimer' s disease

J. Joyce, S. Goldsmith, 1995, Biological Psychiatry.

Visualization of dopamine D3-like receptors in human brain with [125I]epidepride.

J. Joyce, H. Ryoo, A. M. Murray, 1992, European journal of pharmacology.

Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra

D. Mash, G. Stebbins, E. Mufson, 1999, The Journal of comparative neurology.

Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja.

J. Joyce, E. Gurevich, J. Himes, 1999, The Journal of pharmacology and experimental therapeutics.

Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.

J. Joyce, B. Neal, 1991, Brain research. Developmental brain research.

Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases

J. Joyce, 1993, Brain Research.

Thalamo-cortical afferents control transient expression of the dopamine D(3) receptor in the rat somatosensory cortex.

R. Robertson, J. Joyce, E. Gurevich, 2001, Cerebral cortex.